SCHEMBL12840355

SCHEMBL12840355

CC(C)Cc1nc(-c2ccccc2)cnc1NC(=O)CCCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.47
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
HPGD P15428 1/20 0.47
LMNA P02545 2/20 0.46
ALDH1A1 P00352 2/20 0.46
GAA P10253 1/20 0.46
PKM P14618 1/20 0.46
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
HDAC1 Q13547 1/20 0.42
TRPV1 Q8NER1 1/20 0.42
KDM6B O15054 1/20 0.42
KDM4D Q6B0I6 1/20 0.42
KDM4C Q9H3R0 1/20 0.42
ADORA1 P30542 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
NFKB1 P19838 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12838483 0.94 TRPV1 (0.49) SMN1; SMN2NPC1RAB9AHPGDLMNA
SCHEMBL12839674 0.93 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9AHPGDLMNA
SCHEMBL12840035 0.93 LMNA (0.44) SMN1; SMN2NPC1RAB9AHPGDLMNA
SCHEMBL12839648 0.91 ALDH1A1 (0.48) SMN1; SMN2NPC1RAB9AHPGDALDH1A1
SCHEMBL12840352 0.88 NPC1 (0.50) SMN1; SMN2NPC1RAB9AALDH1A1GAA
SCHEMBL12839920 0.88 ALDH1A1 (0.50) SMN1; SMN2NPC1RAB9AALDH1A1GAA
SCHEMBL12839946 0.87 NPC1 (0.49) SMN1; SMN2NPC1RAB9AALDH1A1GAA
SCHEMBL12840374 0.87 TMIGD3 (0.49) SMN1; SMN2NPC1RAB9ALMNAALDH1A1
SCHEMBL12838997 0.87 ALDH1A1 (0.49) SMN1; SMN2NPC1RAB9AALDH1A1GAA
SCHEMBL12839673 0.87 RAB9A (0.43) NPC1RAB9ALMNAALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110070656-A1 Fluorescent Proteins JNC CORPORATION (JP) 2011-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110070656-A1 Fluorescent Proteins CACYBP, CHLSN, LCP2 SMN1; SMN2 4784/4885NPC1 2936/4885RAB9A 2980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.